10/28/2026
Pharma giants invest billions in psychedelics despite hurdles
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
Topic archive
2 stories
10/28/2026
Psychedelics like MDMA and psilocybin gain traction amid regulatory challenges.
10/22/2026
Federal officials discuss the complexities of psychedelic access for veterans.